BioCentury | Sep 26, 2005
Company News

Esprit, Metagen Pharmaceuticals Inc. deal

...or diagnostic procedures in the lower urinary tract. Esprit Pharma Inc. , East Brunswick, N.J. Metagen Pharmaceuticals...
BioCentury | Mar 4, 2002
Company News

InforSense, metaGen Pharmaceuticals GmbH, MicroDiscovery GmbH deal

...its GeneSpotter software to analyze transcription data from DNA chips. InforSense Ltd. , London, U.K. metaGen Pharmaceuticals...
BioCentury | Dec 24, 2001
Strategy

MorphoSys: Call it transformational

...Incyte Pharmaceuticals Inc. (INCY, Palo Alto, Calif.) and the pharma company's recent cancer genomics spinout metaGen Pharmaceuticals...
BioCentury | Mar 26, 2001
Company News

metaGen GmbH, Apax Partners & Co., Schering deal

...43.5 percent stake, and metaGen’s management holds 6.5 percent. metaGen will change its name to metaGen Pharmaceuticals...
Items per page:
1 - 4 of 4
BioCentury | Sep 26, 2005
Company News

Esprit, Metagen Pharmaceuticals Inc. deal

...or diagnostic procedures in the lower urinary tract. Esprit Pharma Inc. , East Brunswick, N.J. Metagen Pharmaceuticals...
BioCentury | Mar 4, 2002
Company News

InforSense, metaGen Pharmaceuticals GmbH, MicroDiscovery GmbH deal

...its GeneSpotter software to analyze transcription data from DNA chips. InforSense Ltd. , London, U.K. metaGen Pharmaceuticals...
BioCentury | Dec 24, 2001
Strategy

MorphoSys: Call it transformational

...Incyte Pharmaceuticals Inc. (INCY, Palo Alto, Calif.) and the pharma company's recent cancer genomics spinout metaGen Pharmaceuticals...
BioCentury | Mar 26, 2001
Company News

metaGen GmbH, Apax Partners & Co., Schering deal

...43.5 percent stake, and metaGen’s management holds 6.5 percent. metaGen will change its name to metaGen Pharmaceuticals...
Items per page:
1 - 4 of 4